Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
No adverse media involving Better found in HSH's search of the last 24 months.
Data breaches, cyber incidents, regulator action and assurance status.
No data breaches, cyber incidents or regulator action involving Better found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
No recalls, safety notices or clinical safety incidents involving Better or its Better Meds ePMA product found in HSH's search of the last 24 months.
Contract delivery, go-lives, terminations and disputes.
Jun 2026: Powys Teaching Health Board went live with Better's ePMA, following other NHS Wales wins including Velindre University NHS Trust (Dec 2025) and Aneurin Bevan University Health Board (Feb 2025).